No Detail Found!

Effect of oral ondansetron on gastrointestinal transit time when used in combination with oral rehydration therapy in acute gastroenteritis

Author(s)
Mehwish Amin Departments of Pharmacology, Army Medical College, Rawalpindi, Pakistan
Muhammad Waqar Aslam Khan Departments of Pharmacology, CMH Kharian Medical College, Pakistan
Abeera Sikandar Departments of Pharmacology, Wah Medical College, Pakistan
Abstract
Objective: To assess the effect of oral ondansetron on gastrointestinal transit time in acute gastroenteritis and to compare the efficacy of ORS alone and in combination with oral ondansetron in improving oral rehydration in acute gastroenteritis. Methodology: This comparative analytic study was conducted at Army Medical College in collaboration with pediatric department of Military Hospital, Rawalpindi from January to November 2017. The study included 210 children of age 2-5 years with clinical diagnosis of acute gastroenteritis with mild to moderate dehydration and with at least two episodes of nonbloody loose stools and abdominal pain. All children were randomized into three equal groups with 70 children in each group. Group 1 received only ORS for rehydration, Group 2 received oral ondansetron as single dose at the time of enrollment and after an interval of 30 minutes, ORT was started as per WHO guidelines and Group 3 received ORS for first 30 minutes and then oral ondansetron. Clinical characteristics were assessed before and after four hours of treatment. Children were assessed after every 30 minutes for the first four hours for the number of episodes of loose stools and abdominal pain. Results:  A significant difference in frequency of stools and abdominal pain was observed between the three groups (p<0.001). Conclusion:  Ondansetron showed a reduction in frequency of loose stools in acute gastroenteritis when used along with ORS leading to quick recovery in children under 5 years of age. 
Publication Details
Page(s) 479-483
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Abdominal pain, Ondansetron., Acute Gastroenteritis, gastrointestinal transit time
References
Whyte LA,Araji RA,McLoughlin LM .2015 .Guidelines for the management of acute gastroenteritis in children in Europe. Arch Dis Child Educ Pract Ed, 100 : 308-12.
Kumari H,Kumar K,Kumar G,Sharma N. Acute,Gastroenteritis: Its Causes N. Acute,Maintenance N. Acute,Treatment N. Acute .2022 .. J Pharm Neg Results, 21 : 5064-78.
Mushtaq A,Khan S,Zeb F,Ain Q,Syed A .2016 .Risk Factors Associated with Gastroenteritis in Children 2-5 Years of Age Attending Rehman Medical Institute Peshawar. Am J Food Sci Health, 2 : 94-101.
Aghsaeifard Z,Heidari G,Alizadeh R .2022 .Understanding the use of oral rehydration therapy: A narrative review from clinical practice to main recommendations. Health Sci Rep, 5 : e827.
Gunn D,Yeldho C,Hoad C,Menys A,Gowland P,Marciani L .2024 .Mechanisms underlying the laxative effect of lactulose: A randomized placebo‐controlled trial showing increased small bowel water and motility unaltered by the 5‐HT3 receptor antagonist, ondansetron. Neurogastroenterol Motil, : e14754.
Merecz K,Hirsa M,Biniszewska O,Fichna J,Tarasiuk A. .2023 .An overview of 5-HT3 receptor antagonists as a treatment option for irritable bowel syndrome with diarrhea. Expert Opin Pharmacother, 24 : 1189-98.
Smith C,Smith M,Cunningham R,Davis S. .2020 .Recent advances in Antiemetics: New formulations of 5-HT:3: Receptor antagonists in adults. Cancer Nurs, 43 : E217-28.
Levine AC,Barry MA,Gainey M,Nasrin S,Qu K,Schmid CH .2021 .Derivation of the first clinical diagnostic models for dehydration severity in patients over five years with acute diarrhea. PLoS Negl Trop Dis, 15 : e0009266.
Kariyappa M.,Hyperglycemia M. .2015 .Hyperglycemia in grade III and grade IV malnutrition with dehydrating gastroenteritis. JEBMH, 2 : 4623-9.
Danewa AS,Shah D,Batra P,Bhattacharya SK,Gupta P .2016 .Oral ondansetron in management of dehydrating diarrhea with vomiting in children aged 3 months to 5 years: A randomized controlled trial. J Pediatr, 169 : 105-9.
Weghorst AA,Holtman GA,Bonvanie IJ,Wolters PI,Kollen BJ,Vermeulen KM .2021 .Cost-effectiveness of oral ondansetron for children with acute gastroenteritis in primary care: a randomised controlled trial. Br J Gen Pract, 71 : e736-43.
Qamar K,Nchasi G,Mirha HT,Siddiqui JA,Jahangir K,Shaeen SK .2022 .Water sanitation problem in Pakistan: A review on disease prevalence, strategies for treatment and prevention. Ann Med Surg, 104709 : .
Hasso-Agopsowicz M,Lopman BA,Lanata CF,McQuade ET,Kang G,Prudden HJ .2021 .Recommendations for assessing morbidity associated with enteric pathogens. Vaccine, 39 : 7521-5.
Guarino A,Aguilar J,Berkley J,Broekaert I,VazquezFrias R,Holtz L .2020 .Acute gastroenteritis in children of the world: what needs to be done?. J Pediatr Gastroenterol Nutr, 70 : 694-701.
Bonvanie IJ,Weghorst AA,Holtman GA,Russchen HA,Fickweiler F,Verkade HJ .2021 .Oral ondansetron for paediatric gastroenteritis in primary care: a randomised controlled trial. Br J Gen Pract, 71 : e728-35.
Leung AK,Hon KL .2021 .Pediatrics: how to manage viral gastroenteritis. Drugs Context, 10 : .
Rukunuzzaman M,Karim AB,Mazumder W,Nurullah M,Hussain F,Sultana K. .2017 .Approach to a Child with Irritable Bowel Syndrome: A Review. J Natl Inst Neurosci Bangladesh, 2 : 34-9.
Ofei SY,Fuchs GJ .2019 .Principles and practice of oral rehydration. Curr Gastroenterol Rep, 21 : 1-6.
Fugetto F,Filice E,Biagi C,Pierantoni L,Gori D,Lanari M .2020 .Single-dose of ondansetron for vomiting in children and adolescents with acute gastroenteritis-an updated systematic review and meta-analysis. Eur J Pediatr, 179 : 1007-16.
Marchetti F,Bonati M,Maestro A,Zanon D,Rovere F,Arrighini A .2016 .Oral ondansetron versus domperidone for acute gastroenteritis in pediatric emergency departments: Multicenter double blind randomized controlled trial. PloS One, 11 : e0165441.
Hagbom M,Novak D,Ekström M,Khalid Y,Andersson M,Lindh M .2017 .Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial. PloS One, 12 : e0186824.
Gunn D,Topan R,Barnard L,Fried R,Holloway I,Brindle R .2023 .Randomized, placebo‐controlled trial and metaanalysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: the TRITON trial. Aliment Pharmacol Ther, 57 : 1258-71.
Garsed K,Chernova J,Hastings M,Lam C,Marciani L,Singh G .2014 .A randomized trial of ondansetron for the treatment of irritable bowel syndrome with diarrhea. Gut, 63 : 1617-25.
Plasse TF,Barton G,Davidson E,Abramson D,Kalfus I,Fathi R .2020 .Bimodal release ondansetron improves stool consistency and symptomatology in diarrhea-predominant irritable bowel syndrome: a randomized, double-blind, trial. Am J Gastroenterol, 115 : 1466-73.
0

Citations

0

Downloads

62

Views